Key Takeaways ARASTEP trial evaluates darolutamide plus ADT for high-risk biochemical recurrence of prostate cancer, focusing on radiologic progression-free survival (rPFS) by PSMA PET-CT. The study ...

The prostate cancer section is a comprehensive resource for urology news and expert insights. Read more at Urology Times.

Prostate cancer, one of the most common cancers diagnosed in American men, is associated with a lifetime risk of approximately 12.9%. 1,2 An estimated 288,300 new prostate cancer cases will be ...

In this interview, Heather Florio and Stephen J. Walker, PhD, discuss the use of aloe vera in patients with interstitial cystitis. Florio is the CEO of Desert Harvest, and Walker is a professor at the ...

Low-intensity extracorporeal shock wave therapy is a safe treatment for men with erectile dysfunction and might work to improve, or even cure, ED in some patients. But there remain important ...

Non-diabetic men treated with semaglutide (Ozempic/Wegovy) appeared to be at an increased risk for developing erectile dysfunction (ED) and hypogonadism; however, the rate was low at 1.5%, according ...

Dr Hamstra describes the three FDA-approved rectal spacers SpaceOAR, Barrigel, and BioProtect, noting differences in placement technique, advantages, potential risks, and the need for long-term ...

The Centers for Medicare & Medicaid Services (CMS) unveiled the final rule for the Medicare Physician Fee Schedule for 2024 on November 2, 2023. 1 The final rule encompasses changes set to take effect ...

Bicycle modifications can potentially improve genitourinary outcomes after cycling. For example, in our cohort, cyclists who stood more than 20% of the time while cycling and adjusted the handlebar to ...

In this interview, Shawn Zimberg, MD, and Dean Laganosky, MD, discuss the BioProtect Balloon Transplant System, a rectal spacer that received FDA clearance in August 2023 for use during prostate ...

In this interview, Mohit Khera, MD, MBA, MPH, shares insights on the use of testosterone replacement therapy in men with prostate cancer, touching on current evidence and also stressing the importance ...

The AUA released its guidelines in 2018, making a strong recommendation that clinicians should inform patients of the absence of evidence linking testosterone therapy to the development of prostate ...